INS and Hypercholesterolemia: In the present investigation, DEX injection induced insulin resistance, as evidenced by hyperglycemia, hyperinsulinemia, elevated HOMA-IR index, hypercholesterolaemia, hypertriglyceridemia, diminished insulin sensitivity index, and reduced GLUT4 expression in skeletal muscles.